Clinical insight, skin science, and perspectives on precision medicine, skin of color, Ayurveda, and the future of medical aesthetics.
Nobody asks to look like someone else, and yet overtreated faces converge on the same one. Why the two goals diverge, and which one is worth having.
A biostimulator does almost nothing on the day. The collagen and elastin response has been measured month by month, and here is that schedule, with the vial range for every area of the face and body.
Filler is sold by the syringe, and the count is the one number that compares cleanly between clinics. A map of the face, the usual range for each area, and why the place that looks hollow is rarely the place that emptied.
Every area takes a different amount, and the approved dose is a starting point rather than a prescription. A map of the face, what each area takes, and why the forehead is never treated on its own.
What collagen does, when it declines, why aging looks different across ethnicities, and which treatments and at-home habits actually rebuild it.
The face ages in four layers and only one of them is visible. Bone resorbs, fat compartments deflate, and no amount of resurfacing touches either.
Roughly 30 percent of skin collagen goes in the first five years. What changes, what hormone therapy does and does not do for skin, and what works without it.
The majority of clinical research and device testing in medical aesthetics has been conducted on Fitzpatrick Types I through III. Here is what that means for patients with deeper skin tones, and how to navigate treatment safely.
PIH affects patients of all skin tones but presents differently and requires different management depending on melanin concentration.
Melasma is among the most complex pigmentation concerns in dermatology, and it is disproportionately undertreated in patients of color.
It measures how skin reacts to sun, not what color it is, and nothing at all about how skin behaves. What the scale captures, what it misses, and the constitutional questions it never asks.
Acne on testosterone peaks between months six and twelve. Estrogen brings dryness. And 84 percent still report unwanted hair. Most of it is predictable, so most of it can be planned for.
The familiar version of this finding describes a mostly white average. Break it out by race and ethnicity and the direction changes by group, which is where it gets clinically useful.
A sticker on the door is not a clinical decision. The form, the wavelength, the dose, and the willingness to say no.
One of your resident bacteria secretes an antioxidant protein. Another builds the ceramides in your barrier. What testing shows, and what it cannot.
Your genes are the one input in a skin plan that never changes. What the five categories describe, and how to read a result correctly.
Eight measured features, including subsurface UV damage that has not reached the surface yet. What it shows, what the numbers mean, and where it should not be trusted.
Unsupervised machine learning found three natural clusters matching the classical types, agreeing with physician assessment 93.9 percent of the time. The tools for measuring it are still maturing. Both are true, and together they explain how to use it well.
Ayurveda and dermatology describe the same phenotype in two vocabularies. Both concepts rest on self-report. Only one of them gets called unscientific.
One axis tells you how skin reacts. The other tells you what the reaction leaves behind. Knowing only one of them is how a good treatment goes wrong.
Syphilis is called the great imitator because it convincingly resembles acne, psoriasis and half a dozen other things. A rash that will not respond to treatment that should work is information.
Taken after sex rather than every morning, doxycycline does not feel like a medication. Before a laser treatment, it is one.
Two hormones, two entirely different jobs. Most of what people experience as unexplained skin behavior is one of them moving.
Both are hyaluronic acid, placed at different depths, doing different jobs. One changes the quality of the skin and the other changes the shape of the face. Asking for the wrong one is the most common route to a face that looks treated.
One creates the demand and the other supplies the material, which is why the combination is studied as its own treatment. Where they genuinely diverge is the scalp and the under-eye.
Filler adds volume today and can be dissolved. Sculptra and Radiesse build your own collagen over months and cannot be undone. The trade-off is control against longevity.
Dark marks, melasma and sun damage are three different problems, and the same treatment can help one and aggravate another. In deeper skin the main risk of both is causing the pigmentation they were meant to treat.
Join the waitlist and be the first to receive new articles, clinical insights, and early access when Aahana opens.